Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China
· Delayed Price · Currency is CNY 17.50
+0.12 (0.69%)
At close: Apr 28, 2025, 2:57 PM CST
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.09 billion as of May 2, 2025. Its market cap has decreased by -15.88% in one year.
Market Cap
2.09B
Enterprise Value
1.47B
Revenue
125.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.50
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.09B, a decrease of -48.58%. That is a compound annual growth rate of -23.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 2.09B | -34.29% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 324.92B |
| Shenzhen Mindray Bio-Medical Electronics | 265.66B |
| WuXi AppTec | 168.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.88B |
| Aier Eye Hospital Group | 120.68B |
| Sichuan Biokin Pharmaceutical | 114.72B |
| Shanghai United Imaging Healthcare | 108.84B |
| Yunnan Baiyao Group Co.,Ltd | 102.18B |